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Readers are invited to use this article as a self-assess- 
ment exercise and to update their knowledge. 
ILLUSTRATIVE CASE HISTORY 
A 29-year-old man presented in 1994 with a short 
history of present illness. At the age of 6, he had had 
his spleen surgically removed for splenic trauma 
following a road traffic accident. He  also had a history 
of rheumatic fever at  the age of 10 years and had been 
admitted to hospital on three other occasions for 
trauma-related problems, including a fractured clavicle 
in 1977. Before this illness he had generally been fit and 
well. 
O n  the evening before admission he had com- 
plained of a slight headache. The following morning he 
awoke feeling cold and numb, with intermittent hot 
sweats, and his wife noticed mottling of his skin. In a 
short time he became very unwell and was rushed into 
hospital. O n  admission his blood pressure was un- 
recordable, his peripheral pulses were weak and he was 
only just rousable. His eyes were congested and 
hemorrhagic. There was no obvious source for the 
infection; his chest was clear and chest X-ray showed 
no focal abnormalities, there was no neck stiffness, and 
only mild generalized tenderness of the abdomen was 
noted. 
There were no records of pneumococcal immun- 
ization in the patient’s notes. His wife confirmed that 
he was supposed to take penicillin V prophylaxis (250 
mg b.d.), but was not sure whether he took the 
medication regularly. In view of the history of splenec- 
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tomy he was immediately given 2.4 g of benzyl- 
penicillin, followed by cefotaxime 2 g t.d.s. He  was 
transferred to the intensive care unit for ventilatory and 
inotropic support. He continued to deteriorate rapidly 
and developed renal failure and disseminated intra- 
vascular coagulopathy (DIC). Despite full supportive 
care he failed to improve and a little over 24 h after 
admission he died. Blood cultures taken on admission 
grew a fully sensitive Streptococcus pneurnoniae. 
An ante-mortem blood sample was later sent for 
penicillin assay and no penicillin or penicilloic acid was 
detected. 
DISCUSS I0 N PO I NTS 
This case of pneumococcal septicemia in a previously 
well man illustrates how infection can rapidly progress 
in patients who have had their spleens removed. The 
patient quickly developed septic shock, multi-organ 
failure and DIC before dying within 36 h of becoming 
unwell. Splenectomy had been performed 23 years 
previously and this was his first episode of septicemia. 
There was no evidence that he had ever received 
pneuinococcal vaccine and it seemed likely that he was 
not taking penicillin prophylaxis, despite this being 
prescribed for him. 
THE SPLEEN AND INFECTION 
The role of the spleen in host defense has been 
appreciated since 1919, when Morris and Bullock 
concluded that its removal resulted in increased 
susceptibility to infection [l]. The first case of 
overwhelming post-splenectomy infection (OPSI) was 
described in 1929 [2] ,  and awareness of this condition 
increased after a report in 1952 of five cases of severe 
infection in infants who had undergone splenectomy 
for hereditary spherocytosis [3]. The first adult case was 
subsequently reported in 1969 [4] and OPSI is now 
recognized as a lifelong complication of this procedure. 
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MULTIPLE CHOICE QUESTIONS 
I n  earh qf the numbered questions, at least one, and  up to-five, 
of the individual entries are correct. (The answers are at the 
end qf this arfirle.) 
1. The following conditions are recognized to 
be associated with functional hyposplenism 
Dermatitis herpetiformis True/False 
Felty’s syndrome True/False 
Alcoholic liver disease True/False 
Essential thrombocythemia True/False 
Splenic vein thrombosis True/False 
With regard to the functions of  the spleen 
humans 
It  is the main site of phagocytosis 
of circulating antigens highly 
opsonized with specific antibody True/False 
It  has a major role in hemopoiesis 
in the fetus True/False 
It  is the site of final maturation of 
re ticulocytes True/False 
It  is important in regulation of the 
circulating blood volume True/False 
It  is an important site of T-cell 
maturation True/False 
Immunologic consequences of splenectomy 
may include 
Keduced production of specific Igh4 True/False 
Reduced memory B-cell responses True/False 
Reduced iinmune response to 
polysaccharide antigens True/False 
Reduced IgE-mediated mast cell 
degranulation True/False 
Keduced selection of high-affinity, 
antigeri-specific, B-cell clones True/False 
With regard to overwhelming post- 
splenectomy infection (OPSI) 
a) Mortality is around 15% True/False 
b) The overall incidence is 10% per year True/False 
c) The risk of serious infection is highest 
in the first 2 years after splenectomy True/False 
d) It  is more common when splenectoniy 
is performed for Hodgkin’s lymphoma 
than for trauma True/False 
e) Is more common when splenectomy 
is performed in children less than 
5 years old True/False 
5. Infections due to the following organisms 
are more common in hyposplenic patients 
a) Plasmodium~falc~arum True/ False 
b) Cupnocytophaga canimorsus True/False 
c) Stveptobarillus monil$ormis True/False 
d) Babesia bovis True/False 
e)  Pneurnocystk curinii True/False 
6. With regard to the immunization of asplenic 
patients 
a) Immunization is particularly important 
in children less than 2 years old True/False 
b) Protective antibody levels wane more 
rapidly in asplenic patients True/False 
c) Pneumococcal revaccination should 
be performed every 2 years TrueIFalse 
d) Vaccination against Neisseria 
meniugitidis serotypes A, B and C is 
recommended True/False 
e) Most asplenic patients mount an 
adequate immunologic response to 
the conjugate Haemophilus influenzae 
type b (Hib) vaccine True / F als e 
7. With regard to antibiotic prophylaxis in 
asplenic patients 
a) It is especially iiiiportant in children 
under 2 years of age True/False 
b) It  is contraindicated in patients with 
coexistent immunosuppressive disease True/False 
c) Kesistance among potential pathogens 
is an increasing problem True/Falw 
d) It should be lifelong True/ False 
e) I t  is not needed if the patient has 
been shown to have protective levels 
of antibody after immunization True/False 
COMMENTS 
Question 1 
Surgical removal of the spleen is essential in the 
management of patients with splenic rupture following 
trauma. Although total splenectoniy is recognized to be 
safer, a number of conservative surgical approaches 
have been advocated to preserve some iiiiniunologic 
function. Partial splenectomy is the best alternative, and 
the degree of protection from OPSI appears to be 
proportional to the percentage of splenic tissue pre- 
served [5]. Autotransplantation (usually in the omental 
pouch) and splenosis (regeneration of splenic tissue that 
has seeded to the peritoneum during trauma) have both 
been investigated, but the presence of such tissue does 
not imply reliable immune function and Overwhelming 
infection has been associated with these procedures [ 6 ] .  
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Splenectoniy may also be indicated for a number 
of hematologic conditions, which include the hemo- 
lytic anemias (especially hereditary spherocytosis), ideo- 
pathic thrombocytopenic purpura, hairy cell leukemia 
and thalassemia major. Improved imaging techniques 
have reduced its role as a staging procedure for 
lymphomas. Splenectomy is also performed in some 
patients with Gaucher’s disease. 
Congenital hyposplenia is rare and is associated 
with malformations of the heart and gut. Functional 
hyposplenism is associated with a number of con- 
ditions, including sickle cell disease and essential 
thrombocythemia, in which reduced function is due to 
vascular occlusion and autoinfarction of the organ. 
Hyposplenism is present in 10-15% of patients with 
coeliac disease and it is also found in the associated 
condition dermatitis herpetiformis. Reduced function 
has also been reported in systemic lupus erythematosus, 
amyloid, inflammatory bowel disease, alcoholic liver 
disease and graft-versus-host disease complicating bone 
marrow transplantation. Steroids and chemotherapeutic 
agents also cause hyposplenism by suppressing the 
lymphoid white pulp. 
Felty’s syndrome is the association of rheumatoid 
arthritis, splenomegaly and neutropenia, while splenic 
vein thrombosis results in portal hypertension and 
secondary enlargement of the spleen. Neither con- 
dition results in functional hyposplenism. 
Questions 2 and 3 
The spleen has two distinct histologic components: the 
erythroid red pulp and the lymphoid white pulp. The 
red pulp consists of a reticular meshwork (the cords of 
Billroth) and sinuses which are lined with endothelial 
macrophages. During their passage through the red 
pulp, normal erythrocytes, which are deformable, are 
able to pass through the intraendothelial slits in the 
sinus wall and return to the peripheral circulation, 
while old, damaged and parasitized red blood cells 
become trapped in the cords and are destroyed. The red 
pulp is also the main filter of blood-borne antigens and 
is important in the phagocytosis of immune complexes 
and encapsulated bacteria such as Streptococcus pneurnoniae 
[7]. The phagocytosis of bacteria by the splenic micro- 
vasculature occurs after deactivation and opsonization 
by complement (particularly C3) and, to a lesser extent, 
by antibodies to form immune complexes. These are 
then taken up by the periarterial macrophages, which 
bear specialized complement and immunoglobulin Fc 
receptors [8 ] .  Because of the efficiency of this filtering 
system and the slow passage of blood through the 
spleen, which maximizes contact with phagocytic cells, 
the degree of opsonization needed for removal is 
relatively low [9]. The spleen is therefore crucial in the 
clearance of organisms early in the course of an 
infection before specific antibody production is fully 
established and is also important in removing bacteria 
opsonized with complement alone [lo]. After splenec- 
tomy, the macrophages of the liver and other lymphoid 
organs are partially able to take over this function, but 
require higher levels of specific antibody to facilitate 
clearance [9]. 
The red pulp has a minor role in hemopoiesis in 
the human fetus from 12 weeks of gestation. Although 
this function is lost soon after birth, extramedullary 
hemopoiesis can be reactivated under conditions of 
hematologic stress. Sequestration of reticulocytes is also 
an important function and these complete their final 2 
to 3 days oEmaturation in the cords oEBillroth. Up to 
45% of the total platelets may be also be sequestered in 
the spleen, and can be mobilized and released when 
needed. Although the spleen has a significant physio- 
logic role in the regulation of the blood volume in dogs, 
this function is not important in humans. 
The lymphoid white pulp consists of the central 
splenic arterioles surrounded by lymphoid tissue. 
Immediately surrounding the central arterioles is the 
periarteriolar lymphatic sheath, which is densely popu- 
lated with small T-lymphocytes and dendritic antigen- 
presenting cells (interdigitating cells). At intervals along 
the sheath are the Malpighian bodies, which struc- 
turally resemble lymphoid follicles, and these are 
surrounded by the marginal zone. Both areas mainly 
consist of recirculating B-lymphocytes. After B-cell 
activation by an antigen, a germinal center of rapidly 
dividing cells forms in the center of the follicle and 
high-affinity, antigen-specific B-cell clones are selected 
[l  I]. During the primary humoral response the white 
pulp is therefore an important site of specific IgM 
production [12]. The response is maintained by the 
follicular dendritic cells, which can take up and retain 
antigens in the form of immune complexes for pro- 
longed periods of time [13] and hence promote 
production of late-phase antibodies and the develop- 
ment of a memory response [ l l ] .  
The spleen has a pivotal role in the host’s response 
to encapsulated organisms. Although this response is 
independent of the actual presence of T-cells, it requires 
T-cell-produced factors and is known as the thymus- 
independent antigen type 2 (TI-2) response [14]. 
Specialized macrophages within the marginal zone are 
capable of taking up carbohydrate antigens such as 
capsular polysaccharides and initiating the TI-2 
response [15]. B-cells within the marginal zone pro- 
duce antibodies (mainly IgM and IgG2) to polysac- 
charide antigens and these are important for the 
opsonization and phagocytosis of encapsulated organ- 
isms [16]. It has been shown that the maturation of 
J e n k s :  I n f e c t i o n s  i n  a s p l e n i c  p a t i e n t s  269  
marginal zone B-cells coincides with the ability to 
make antibodies to carbohydrate antigens [ 171. Children 
under the age of 2 years are unable to synthesize 
adequate IgG2 and hence respond poorly to poly- 
saccharide vaccines [18). Splenectomy significantly 
reduces the reservoir of polysaccharide responsive B- 
cells and although there are small numbers of these cells 
in other lymphoid organs, there are not sufficient to 
restore full immunologic function [ 191. Therefore, 
removal of the spleen not only results in the loss of the 
most important filter of encapsulated organisms, but 
also reduces the main immunologic response to their 
polysaccharide antigens. This effect is particularly 
significant in children, who have lower pre-existing 
immunity to these organisms. 
The spleen also produces two important opsonins 
[ZO]. Tuftsin is a tetrapeptide that increases Fc-depen- 
dent phagocytosis in polymorphonuclear leukocytes 
and increases the activity and migration of phagocytes, 
and properdin is a component of the alternative 
complement pathway. 
Specific cells in the spleen also process and present 
antigens to splenic T-cells, and hence the delayed-type 
hypersensitivity reaction is reduced in splenectomized 
patients, as is overall T-cell function. It  is not, however, 
an important site for T-cell maturation, as T-cells 
develop almost exclusively in the thymus. The spleen 
has no role in IgE-mediated immune responses. 
Question 4 
A number of infections are more common in splenec- 
tomized patients, but OPSI is a distinct clinical 
syndrome characterized by its rapid onset and ful- 
niinant progression. Clinical features include septi- 
cemia in the absence of a focus, coma, multiple organ 
failure, disseminated intravascular coagulopathy and 
bilateral adrenal hemorrhage, and mortality exceeds 
50% in most series [21]. 
The overall risk of OPSI is small, and a recent study 
estimated the incidence of severe late post-splenectoniy 
infection to be 0.42 per 100 person years (i.e. one 
patient will develop severe sepsis once in 238 years) 
[22]. The incidence of overwhelming infection is 
dependent on underlying disease, and patients with 
underlying hematologic disorders, such as the lympho- 
reticular malignancies and thalassemia, are particularly 
at  risk [22). The incidence is lowest for splenectomy 
performed after trauma, and it has been suggested that 
splenic removal in this group is associated with minimal 
increased risk of infection [23]. Although the absence 
of a spleen in an otherwise immunocoinpetent adult is 
certainly conipatible with a healthy life, it has to be 
remembered that the risk of rapidly progressive life- 
threatening disease remains in all patients. 
OPSI is also more comnion in children, and those 
under S years of age are particularly at risk [23]. In all 
patients the risk of OPSI is greatest in the early 
postoperative period, and most infections occur in the 
first 2 years after operation [24]. However, infections 
have been reported 25 years after surgery, and the risk 
is generally considered to be lifelong [2S]. 
Question 5 
Overwhelming infection after splenectoniy is usually 
due to Streptococcus pneumoniae (-50% of cases), Haemo- 
philus injuenzae or Neissevia menirgitidis (261. Infections 
with Eschevichia coli, Pseudomonas aeruginosa, P-hemolytic 
streptococci and certain viruses, including influenza, 
are also more common in these patients. 
Capnocytophaga canimorsus (previously known as 
dysgonic fermenter 2) bacteremia often results in 
fulminant sepsis in asplenic patients [27]. This has led 
to the recommendation that such patients avoid dog 
bites and scratches, and that, if exposure does occur, 
empirical treatment with anioxycillin/clavulanate or 
erythromycin should be started [28]. 
The spleen is important in the host response to 
malaria; as well as removing parasitized red cells, it is 
also the site of production of antimalarial antibodies and 
is involved in the cellular response to the parasite 1291. 
Increased susceptibility of asplenic patients to malaria 
has recently been confirmed in a large study in Papua 
New Guinea [30]. Patients traveling to nialarious areas 
need to be aware of this risk, and the importance of 
chemoprophylaxis and prevention of exposure to mos- 
quitoes should be emphasized. In most cases, avoidance 
of endemic areas is preferable, whatever the reason for 
travel. Geoffrey Boycott, the British cricketer, who had 
a splenectomy at the age of 7 years after falling off some 
railings onto a mangle, decided not to participate in 
England cricket tours to the Indian subcontinent 
because of the potential risk of serious infection [31]. 
Splenectomized patients are also more susceptible 
to babesiosis, an intraerythrocytic protozoal infection 
transmitted by Ixodes ticks [32]. In Europe all nine 
reported cases have been in splenectomized patients 
and have been of the bovine type (Babesia bovis and 
Babesia diveyens), with the majority of patients dying of 
a fulminant febrile hemorrhagic disease [33]. In the 
USA the rodent strain, Babesia micvoti, predominates, 
but only 30% of cases have been associated with 
asplenia, and most patients have survived (331. 
Question 6 
Immunization aims to reduce the risk of overwhelming 
infection due to encapsulated organisms, and a 
significant reduction in medium-term pneumococcal 
infections has been observed in Danish children 
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immunized with polyvalent pneumococcal vaccine after 
splenectomy [34]. The currently available pneurno- 
coccal vaccine (Pneumovax 23) covers 23 serotypes 
responsible for over 80% of bacterernic pneumococcal 
disease, and provides protective antibody in -95% 
of eusplenic patients [35]. Most immunocompetent 
asplenic adults have an intact antibody response to 
polysaccharide vaccines, and the response to Pneunio- 
vax in this group is at least 85% [36]. To optimize the 
response, vaccination should be carried out at least 2 
weeks before surgery, but in emergency cases the 
vaccine may be given in the immediate postoperative 
period [37]. The response to immunization after 
splenectomy is impaired in patients with altered 
immune function and is particularly poor in patients 
with hematologic malignancies treated with chemo- 
therapy and radiotherapy. Improved results can be 
achieved if vaccination is carried out 2 weeks before 
immunosuppressive therapy is started [38]. Immu- 
nization is particularly important in children, who will 
have had limited previous exposure to encapsulated 
organisms, but should be delayed until after 2 years of 
age, as before this the response to polysaccharide 
vaccines is minimal [17]. 
It is well recognized that induced antibody levels 
wane more rapidly in asplenic individuals, and 
consequently revaccination in the United Kingdom 
is recommended every 5 to 10 years [39]. Newer 
recommendations, for the relicensed vaccine (Pneumo- 
vax 11), advise revaccination of high-risk children after 
3 to 5 years but not within 3 years [40]. Although 
earlier boosting has been advocated by some authors, 
revaccination in the presence of high antibody levels 
can be associated with adverse side effects, including 
local erythema, pain and serum sickness [41]. It has 
therefore been suggested that specific antibody levels 
should be monitored annually to determine the most 
appropriate time for revaccination and that assays for 
opsonizing activity should be used to assess their 
functional ability to stimulate phagocytosis [41]. 
Unfortunately, such assays are not widely available. It is 
hoped that with the development of new conjugate 
vaccines efficacy will improve in all patient groups and 
guidelines on the timing of revaccination will become 
clearer. 
Most centers also recommend vaccination against 
H .  injuenzae type b, N. meningitidis serogroups A and 
C and influenza. Asplenic patients without underlying 
disease have been shown to achieve protective antibody 
levels when immunized with the current Hib conjugate 
vaccine [42] and obtain similar responses to healthy 
individuals with the current bivalent meningococcal 
vaccine (A and C) [43]. Type B rneningococcus, which 
causes the majority of invasive hsease, is not covered 
by the current vaccine owing to the reduced immuno- 
genicity of the type B polysaccharide [43]. Data on 
revaccination with these two vaccines are not available. 
Question 7 
The role of antibiotic prophylaxis in the management 
of splenectomized patients is controversial. The 
argument for chemoprophylaxis is that immunization 
does not cover all potential pathogenic serotypes and 
does not completely compensate for the loss of the 
splenic filter. Cases of fatal septicemia have been 
reported despite full courses of vaccination [44]. The 
antibiotics usually used are oral penicillin or erythro- 
mycin. Amoxycillin may be a better choice than 
penicillin, as it has better oral bioavailability and is a 
broader-spectrum agent. Prophylactic penicillin has 
been shown to be valuable in reducing pneumococcal 
sepsis by over 80% in children with sickle cell disease 
[45], but it is unclear whether these data can be 
extrapolated to asplenic patients. 
Recommendations for asplenic patients vary from 
lifelong daily penicillin in children or adults [46] to the 
assertion that there is no evidence that antibiotic 
prophylaxis is needed in vaccinated patients, as vaccine 
failure is very rare [47]. It is generally agreed that it 
should be given to children too young to mount a 
protective immunologic response to vaccination (all 
children under 5 years without a spleen) and recom- 
mendations in the UK are that daily oral penicillin 
should be given to children under 16 years [48]. It 
should also be given to patients with coexistent 
immunosuppressive disease, as they also will respond 
poorly to imniunization, and to all adults for the first 2 
years after splenectomy, when the risk of OPSI is 
greatest. An alternative approach, particularly in lower- 
risk groups or those unable to take daily prophylaxis, is 
to issue patients with an emergency supply of an 
antibiotic to take if they develop a febrile illness or 
become unwell. 
Antibiotic prophylaxis has now been complicated 
by the emergence of resistance amongst potential 
pathogens, and a case of penicillin-resistant pneumo- 
coccal meningitis has been described in a patient on 
long-term ampicillin prophylaxis [49]. Other failures of 
treatment have been due to non-compliance, which is 
not surprising, as long-term prophylaxis is unrealistic 
for many patients [50]. Although trials are needed to 
define which groups are most likely to benefit from 
chemoprophylaxis and for how long they need to be 
treated, these are difficult to design because of the low 
incidence of OPSI. 
Education of clinicians and patients is also im- 
portant in preventing OPSI, and, although protocols 
exist in many centers, studies have demonstrated 
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deficiencies in advice given to patients by clinicians [51] 
and in patient awareness of their increased risk of 
serious infection [52]. Patients need to be informed of 
their increased susceptibility to infection and advised to 
present early if they become unwell. Warning devices 
for patients are advocated and these include Medic- 
Alert necklaces/bracelets and cards. Hospital discharge 
letters should inform the general practitioner of the 
splenectomy, whether immunization has been given 
and whether chemoprophylaxis is indicated, 
SUMMARY 
In general it is recommended that all asplenic patients 
should receive immunization against Streptococcus pneu- 
moniae, H. infuenzae type b and N. meningitidis types A 
and C. Annual influenza vaccine is also often given. 
Prophylaxis with antibiotics should probably be given 
to all children under 5 years of age, to all adults for the 
first 2 years after surgery and for life to patients with 
underlying iumniunosuppressive disease. The use of 
and duration of chemoprophylaxis in other groups 
remains controversial, and the long-term use of anti- 
biotics is unacceptable and unrealistic for many patients. 
Patients should be aware of their increased risk of 
infection and should be advised to obtain early medical 
assessnient if they become ill, and be trained in self- 
medication when they develop a febrile illness. They 
should take appropriate malarial prophylaxis and avoid 
contact with mosquitoes and ticks when traveling to 
areas endemic for malaria and babesiosis. 
Answers to the multiple-choice questions 
41: a. True; b. False; c. True; d. True; e. False 
4 2 :  a. False; b. False; c. True; d. False; e. False 
4 3 :  a. True; b. True; c. True; d. False; e. True 
4 4 :  a. False; b. False; c. True; d. True; e. True 
4 5 :  a. True; 13. True; c. False; d. True; e. False 
4 6 :  a. False; b. True; c. False; d. False; e. True 
47: a. True; b. False; c. True; d. False; e. False 
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